Market Overview:
The global ceruloplasmin determination kit market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of copper-related disorders, rising demand for point-of-care testing, and technological advancements in ceruloplasmin assay kits. However, the high cost of advanced assay kits may restrain the growth of this market during the forecast period. Based on type, nephelometry accounted for a larger share of the global ceruloplasmin determination kit market in 2017. This segment is expected to grow at a CAGR of 5.8% from 2018 to 2030 due to its advantages such as accuracy and speed over other methods such as immunoturbidimetry and colorimetry.
Product Definition:
The Ceruloplasmin Determination kit is a test used to measure the amount of ceruloplasmin in blood. Ceruloplasmin is an important protein that helps move copper around the body. A low level of ceruloplasmin can indicate a problem with copper metabolism.
Nephelometry:
Nephelometry is the technique of measuring the rate and amount of fluid entering or leaving a body organ, tissue, blood vessel or coming into contact with another body part. Nephelometry helps in diagnosing certain diseases such as kidney disorders, diabetes mellitus and other metabolic abnormalities. It also helps in monitoring certain drugs that are given to patients for treatment purposes.
Immunoturbidimetry:
Immunoturbidimetry is a test that helps in the detection of low levels of free tau protein in the blood. It also helps to detect early signs of Alzheimer's disease, frontotemporal dementia, and other neurodegenerative diseases.
Application Insights:
The other application segment includes research institutes and industrial manufacturing facilities. Other applications of NCPD include the detection of liver disorders, kidney disorders, and eye diseases. Ceruloplasmin determination is used to screen for various conditions including hemochromatosis, primary hyperoxaluria (PHO), Hunter¢â‚¬â„¢s syndrome (HS), cystinosis, aminoaciduria and others.
In 2017, the hospitals segment dominated the global ceruloplasmin determination kit market with a revenue share of over 60%. The dominance is attributed to factors such as rising prevalence of chronic diseases such as cancer & diabetes which involves monitoring blood tests at regular intervals. In addition, an increase in hospital admissions for acute illnesses also contributes towards a significant demand for hematology analyzers across hospitals globally.
Regional Analysis:
North America dominated the global market in 2017. This is due to the high prevalence of MPS III and IV, increasing awareness about associated disorders, availability of effective treatment methods such as plasma exchange therapy (PET) and increased government funding for research & development activities pertaining to rare diseases.
Asia Pacific is expected to grow at a lucrative rate over the forecast period owing to rising disposable income levels, improving healthcare infrastructure along with an increase in disease prevalence especially neonatal diabetes which is further fueling growth. Moreover, growing medical tourism industry will also contribute towards regional market growth during the forecast period. Increasing investments by major players for product innovation coupled with collaborations undertaken by them will also boost demand for ceruloplasmin determination kit in this region. For instance; In January 2018; Bio-Rad Laboratories entered into distribution agreement with Sinopharm Chemical Information Co., Ltd.
Growth Factors:
- Increasing demand for early diagnosis of various diseases
- Rising prevalence of chronic diseases
- Technological advancements in diagnostics industry
- Growing awareness about health and wellness among people
- Increasing investments by private players in the healthcare sector
Scope Of The Report
Report Attributes
Report Details
Report Title
Ceruloplasmin Determination Kit Market Research Report
By Type
Nephelometry, Immunoturbidimetry
By Application
Hospitals, Clinics, Other
By Companies
Siemens, Danaher, SENTINEL CH. SpA, LifeSpan BioSciences, Biomatik, Cell Sciences, Bio-Techne, Biorbyt, G Biosciences, OriGene Technologies, CUSABIO Technology LLC
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
202
Number of Tables & Figures
142
Customization Available
Yes, the report can be customized as per your need.
Global Ceruloplasmin Determination Kit Market Report Segments:
The global Ceruloplasmin Determination Kit market is segmented on the basis of:
Types
Nephelometry, Immunoturbidimetry
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Siemens
- Danaher
- SENTINEL CH. SpA
- LifeSpan BioSciences
- Biomatik
- Cell Sciences
- Bio-Techne
- Biorbyt
- G Biosciences
- OriGene Technologies
- CUSABIO Technology LLC
Highlights of The Ceruloplasmin Determination Kit Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Nephelometry
- Immunoturbidimetry
- By Application:
- Hospitals
- Clinics
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Ceruloplasmin Determination Kit Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
The Ceruloplasmin Determination Kit is a laboratory test that determines the level of ceruloplasmin in blood. Ceruloplasmin is a protein that helps to transport cholesterol and other lipids in the blood. A low level of ceruloplasmin may indicate an increased risk for heart disease, stroke, or other serious health problems.
Some of the major companies in the ceruloplasmin determination kit market are Siemens, Danaher, SENTINEL CH. SpA, LifeSpan BioSciences, Biomatik, Cell Sciences, Bio-Techne, Biorbyt, G Biosciences, OriGene Technologies, CUSABIO Technology LLC.
The ceruloplasmin determination kit market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Ceruloplasmin Determination Kit Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Ceruloplasmin Determination Kit Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Ceruloplasmin Determination Kit Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Ceruloplasmin Determination Kit Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Ceruloplasmin Determination Kit Market Size & Forecast, 2018-2028
4.5.1 Ceruloplasmin Determination Kit Market Size and Y-o-Y Growth
4.5.2 Ceruloplasmin Determination Kit Market Absolute $ Opportunity
Chapter 5 Global Ceruloplasmin Determination Kit Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Ceruloplasmin Determination Kit Market Size Forecast by Type
5.2.1 Nephelometry
5.2.2 Immunoturbidimetry
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Ceruloplasmin Determination Kit Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Ceruloplasmin Determination Kit Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Ceruloplasmin Determination Kit Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Ceruloplasmin Determination Kit Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Ceruloplasmin Determination Kit Analysis and Forecast
9.1 Introduction
9.2 North America Ceruloplasmin Determination Kit Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Ceruloplasmin Determination Kit Market Size Forecast by Type
9.6.1 Nephelometry
9.6.2 Immunoturbidimetry
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Ceruloplasmin Determination Kit Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Ceruloplasmin Determination Kit Analysis and Forecast
10.1 Introduction
10.2 Europe Ceruloplasmin Determination Kit Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Ceruloplasmin Determination Kit Market Size Forecast by Type
10.6.1 Nephelometry
10.6.2 Immunoturbidimetry
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Ceruloplasmin Determination Kit Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Ceruloplasmin Determination Kit Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Ceruloplasmin Determination Kit Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Ceruloplasmin Determination Kit Market Size Forecast by Type
11.6.1 Nephelometry
11.6.2 Immunoturbidimetry
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Ceruloplasmin Determination Kit Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Ceruloplasmin Determination Kit Analysis and Forecast
12.1 Introduction
12.2 Latin America Ceruloplasmin Determination Kit Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Ceruloplasmin Determination Kit Market Size Forecast by Type
12.6.1 Nephelometry
12.6.2 Immunoturbidimetry
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Ceruloplasmin Determination Kit Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Ceruloplasmin Determination Kit Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Ceruloplasmin Determination Kit Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Ceruloplasmin Determination Kit Market Size Forecast by Type
13.6.1 Nephelometry
13.6.2 Immunoturbidimetry
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Ceruloplasmin Determination Kit Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Ceruloplasmin Determination Kit Market: Competitive Dashboard
14.2 Global Ceruloplasmin Determination Kit Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Siemens
14.3.2 Danaher
14.3.3 SENTINEL CH. SpA
14.3.4 LifeSpan BioSciences
14.3.5 Biomatik
14.3.6 Cell Sciences
14.3.7 Bio-Techne
14.3.8 Biorbyt
14.3.9 G Biosciences
14.3.10 OriGene Technologies
14.3.11 CUSABIO Technology LLC
